Plain-English translation of NCT04228211 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This is a registry study — think of it as a long-term tracking system — for men newly diagnosed with prostate cancer. Researchers will collect your clinical information and ask you to fill out questionnaires about your health and quality of life. The goal is to create a database that can be used to test new prostate cancer treatments fairly and efficiently in the future.
Prostate cancer treatments vary widely, and doctors need better ways to test whether new approaches actually work. By building a large, organized registry of patients over time, researchers can compare how different treatments affect real patients' lives and outcomes.
You likely qualify if…
You likely don't qualify if…
You will be enrolled in the registry when you start prostate cancer treatment (surgery, radiation, watchful waiting, or active surveillance). Over time, the research team will collect your clinical information from routine appointments and ask you to complete questionnaires about your symptoms, side effects, and quality of life. The study continues long-term to track how you're doing after treatment, and you may eventually be invited to participate in specific new treatment studies if you qualify.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Netherlands
Sponsor
UMC Utrecht
Collaborators
St. Antonius Hospital
Enrollment target
~1,500 participants
Started
February 2020
Primary completion
February 2030
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Frederik R. Teunissen, MD
UMC Utrecht
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.